Pub. L. 119-60, div. H, tit. LXXXIII, subtit. B, sec. 8315 (as amended)
PRIORITIZATION OF IDENTIFICATION OF PERSONS FROM THE PEOPLE’S REPUBLIC OF CHINA.
SEC. 8315. PRIORITIZATION OF IDENTIFICATION OF PERSONS FROM THE PEOPLE’S REPUBLIC OF CHINA.
Section 7211 of the Fentanyl Sanctions Act (21 U.S.C. 2311) is amended—
(1) in subsection (a)—
(A) in paragraph (1)—
(i) in subparagraph (B), by striking “and” at the end;
(ii) in subparagraph (C), by striking the period at the end and inserting “; and”; and
(iii) by adding at the end the following:
“(D) assessing whether any senior official of any anti-narcotics, regulatory, law enforcement, intelligence, or customs body of the People’s Republic of China—
“(i) has directly or indirectly taken actions that have facilitated or advanced foreign opioid trafficking; and
“(ii) should be identified as a foreign opioid trafficker.”
;
(B) by redesignating paragraphs (3) and (4) as paragraphs (4) and (5), respectively; and
(C) by inserting after paragraph (2) the following:
“(3) Prioritization.—
“(A) Defined term.—In this paragraph, the term ‘person of the People’s Republic of China’ means—
“(i) an individual who is a citizen or national of the People’s Republic of China; or
“(ii) an entity organized under the laws of the People’s Republic of China or otherwise subject to the jurisdiction of the Government of the People’s Republic of China.
“(B) In general.—In preparing the report required under paragraph (1), the President shall direct the Secretary of the Treasury to prioritize, to the greatest extent
practicable, the identification of persons of the People’s Republic of China involved in the shipment of fentanyl, fentanyl analogues, fentanyl precursors, precursors for fentanyl analogues, pre-precursors for fentanyl and fentanyl analogues, and equipment for the manufacturing of fentanyl and fentanyl-laced counterfeit pills to Mexico or any other country that is involved in the production of fentanyl trafficked into the United States, including—
“(i) any entity involved in the production of pharmaceuticals; and
“(ii) any person that is acting on behalf of any such entity.
“(C) Termination of prioritization.—The President shall continue the prioritization required under subparagraph (B) until the President certifies to the appropriate congressional committees that the People’s Republic of China is no longer the primary source for the shipment of fentanyl, fentanyl analogues, fentanyl precursors, precursors for fentanyl analogues, pre-precursors for fentanyl and fentanyl analogues, and equipment for the manufacturing of fentanyl and fentanyl-laced counterfeit pills to Mexico or any other country that is involved in the production of fentanyl trafficked into the United States.”
; and
(2) in subsection (c), by striking “the date that is 5 years after such date of enactment” and inserting “December 31, 2030”.